FARICIMAB

1 FDA products 1 manufacturers INTRAVITREAL

FARICIMAB is an active ingredient listed in 1 FDA drug label records from 1 manufacturers taken by intravitreal route marketed mainly as human prescription drug products.

About FARICIMAB

FARICIMAB appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from Genentech, Inc.. In this ingredient’s product set, the most common route of administration is intravitreal. Approved labelling for these products most frequently references: macular edema, vabysmo vascular, endothelial growth, factor vegf, ang- inhibitor, treatment patients, neovascular wet, degeneration namd. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.

How it is supplied

Dosage formProductsRouteProducts
— — INTRAVITREAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

Main manufacturers

ManufacturerProductsMarketing type
Genentech, Inc. 1 HUMAN PRESCRIPTION DRUG

FDA drug products containing FARICIMAB

Brand nameManufacturerTypeRouteDosage form
VABYSMO Genentech, Inc. HUMAN PRESCRIPTION DRUG INTRAVITREAL

Frequently asked questions

How many FDA drug products contain FARICIMAB?
1 FDA drug label records list FARICIMAB as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.

Which companies make FARICIMAB products?
The manufacturers with the most FARICIMAB label records are Genentech, Inc.. Generic and brand versions may be produced by different companies.

Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.

This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.